Nxn.Ax
NxN operates in the healthcare diagnostics sector, providing diagnostic solutions and related services to healthcare providers and patients.
Business. NxN operates in the healthcare diagnostics sector, providing diagnostic solutions and related services to healthcare providers and patients.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
NxN operates in the healthcare diagnostics sector, providing diagnostic solutions and related services to healthcare providers and patients.
NxN's capital structure is highly leveraged, with total liabilities of AUD 3.37 billion and total equity of AUD -116.24 million, resulting in a debt-to-equity ratio of -26.84. The company's liquidity position is weak, as indicated by a current ratio of 0.38, suggesting that it may struggle to meet short-term obligations without external financing.
Profitability metrics reveal significant challenges. The company reported a net loss of AUD 5.02 billion and an operating loss of AUD 2.68 billion, with a return on assets of -1.54%. These figures are well below the industry median for profitability, indicating that NxN is underperforming relative to its peers in terms of generating returns from its asset base.
NxN's revenue is concentrated in a single geographic market, with all reported revenue generated in Australia. The company does not disclose segment-level revenue, making it difficult to assess the contribution of different product lines or geographic regions to overall performance.
The company's growth trajectory is negative, with a net loss of AUD 5.02 billion in the latest reporting period. There is no indication of a turnaround in the near term, as operating cash flow is negative at AUD -3.21 billion, and capital expenditures remain modest at AUD -81.12 million.
Risk factors include a high debt load and negative equity, which increase the company's vulnerability to economic downturns and interest rate fluctuations. The risk assessment indicates a medium liquidity risk, with the company's net cash position being negative after subtracting total debt. Dilution risk is currently low, but the company's negative equity and high debt levels could lead to future share issuance to service debt or fund operations.
Recent events include the filing of the latest financial results, which show continued losses and a deteriorating balance sheet. No significant corporate actions or strategic announcements have been disclosed in the recent filings.
- NxN is operating at a significant net loss, with a net income of -AUD 5.02 billion.
- The company has a highly leveraged capital structure, with a debt-to-equity ratio of -26.84.
- NxN's liquidity position is weak, as indicated by a current ratio of 0.38.
- The company's profitability is below industry medians, with a return on assets of -1.54%.
- NxN's revenue is entirely concentrated in Australia, with no disclosed segment-level breakdown.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- NXN.AX Market data — financials · 2026-05-28